Back to search
FDAFDA · Food and drugs·Recall number Z-2227-2012

Access Total T3 Reagent, PN: 33830 The Access Total T3 assay is used for the quantitative determination of triiodothyronine (T3) levels in human serum and plasma in the assessment of thyroid function and diagnosis of thyroid disorders when T3 levels are between 0.1 and 8.0 ng/mL.

Published August 29, 2012 · Recall initiated: October 11, 2011

Summary

FDA records medical device Class III recall Z-2227-2012, published August 29, 2012 and initiated October 11, 2011. Recalling firm: Beckman Coulter Inc.; Status: Terminated; Reported quantity: 117,385 units total (33,918 units in US); Lot: All Lots. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A recall was initiated because Beckman Coulter has identified a negative bias in test results when comparing elevated Total T3 patient samples diluted with Sample Diluent A to samples diluted with Access Total T3 Calibrator S0.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Beckman Coulter Inc.
Distributor
Worldwide Distribution - USA (nationwide), Canada, and internationally.
Lot
All Lots
Risk classification
Class III
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Access Total T3 Reagent, PN: 33830 The Access Total T3 assay is used for the quantitative determination of triiodothyronine (T3) levels in human serum and plasma in the assessment of thyroid function and diagnosis of thyroid disorders when T3 levels are between 0.1 and 8.0 ng/mL. recalled?

Yes. FDA published recall Z-2227-2012 on August 29, 2012. Reported hazard: A recall was initiated because Beckman Coulter has identified a negative bias in test results when comparing elevated Total T3 patient samples diluted with Sample Diluent A to samples diluted with Access Total T3 Calibrator S0.

What should I do if I have this product?

Voluntary: Firm initiated · Letter